MYCN and neoplasm: In these pediatric tumors, MYCN activates transcription of the miR-17–92 cluster, contributing to tumorigenesis by suppressing differentiation and apoptosis, reinforcing its role as a downstream effector of MYCN-driven tumor biology (41).